Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Supiot

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2018
[Hypofractionnated radiotherapy for elderly patients with prostate cancer]P Sargos, G Créhange, C Hennequin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2009
[Intensity-modulated radiotherapy for cancers in childhood]J Leseur, C Carrie, E Le Prisé, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 31, 2009
[Use of IGRT for prostate cancers (OBI-CBCT Varian, ExacTrac BrainLAB and MVCT TomoTherapy)]G Delpon, C Llagostera, M Le Blanc, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 6, 2014
[Stereotactic body radiation therapy and oligometastases]C Bourgier, D Azria, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 3, 2007
[Alpha-radioimmunotherapy: a review of recent developments]S Supiot, F Thillays, E Rio, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 24, 2023
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovationsL Ollivier, K Debbi, N-H To, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2019
[Stereotactic ablative body radiotherapy: Which machine for which therapeutic indication? A focus on prostate cancer]A Lapierre, S Horn, G Créhange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 23, 2024
[Characteristics of radiotherapy for adolescents and young adults]L Ollivier, A Laprie, E Jouglar, et al.
Clinical and Translational Radiation Oncology|May 8, 2026
A review of clinical trial radiotherapy quality assurance: value, evolution and lessonsG Le Quellenec, T Perennec, L Ollivier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2010
[IMRT combined to IGRT: increase of the irradiated volume. Consequences?]A Lisbona, D Averbeck, S Supiot, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2018
[Hypofractionnated radiotherapy for elderly patients with prostate cancer]P Sargos, G Créhange, C Hennequin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2009
[Intensity-modulated radiotherapy for cancers in childhood]J Leseur, C Carrie, E Le Prisé, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 31, 2009
[Use of IGRT for prostate cancers (OBI-CBCT Varian, ExacTrac BrainLAB and MVCT TomoTherapy)]G Delpon, C Llagostera, M Le Blanc, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 6, 2014
[Stereotactic body radiation therapy and oligometastases]C Bourgier, D Azria, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 3, 2007
[Alpha-radioimmunotherapy: a review of recent developments]S Supiot, F Thillays, E Rio, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 24, 2023
Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovationsL Ollivier, K Debbi, N-H To, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2019
[Stereotactic ablative body radiotherapy: Which machine for which therapeutic indication? A focus on prostate cancer]A Lapierre, S Horn, G Créhange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 23, 2024
[Characteristics of radiotherapy for adolescents and young adults]L Ollivier, A Laprie, E Jouglar, et al.
Clinical and Translational Radiation Oncology|May 8, 2026
A review of clinical trial radiotherapy quality assurance: value, evolution and lessonsG Le Quellenec, T Perennec, L Ollivier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2010
[IMRT combined to IGRT: increase of the irradiated volume. Consequences?]A Lisbona, D Averbeck, S Supiot, et al.
Pageof 8